0000874716-22-000007 Sample Contracts

AGREEMENT
Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York

THIS AGREEMENT is made effective as of the 16th day of October, 2003, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 East Shelby Drive, Memphis, Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).

Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
CEO Restricted Stock Unit Agreement
Restricted Stock Unit Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
Sample 1Sample 2
AMENDMENT NO. 3 TO AGREEMENT
Certain • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances

AMENDMENT, effective as of December 28, 2011 (this “Amendment”) to the Agreement, dated as of October 17, 2003, between IDEXX Europe B.V. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc. (“OCD”).

Sample 1
Restricted Stock Unit Agreement
Restricted Stock Unit Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Delaware
Sample 1
AMENDMENT NO. 4 TO AGREEMENT
Certain • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances

AMENDMENT, effective as of December 28, 2011 (this “Amendment”) to the Agreement, dated as of October 16, 2003, between IDEXX Operations, Inc. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc. (“OCD”).

Sample 1
CEO Stock Option Agreement Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan
Ceo Stock Option Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Delaware
Sample 1
Director Stock Option Agreement Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan
Director Stock Option Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Delaware
Sample 1
Employee Stock Option Agreement Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan
Employee Stock Option Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Delaware
Sample 1
AMENDMENT NO. 6 TO AGREEMENT
Certain • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances

THIS AMENDMENT NO.6 TO AGREEMENT (this “Amendment”) is made effective as of September 1, 2021, between IDEXX Europe B.V., a corporation organized under the law of the Netherlands (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD” or “Ortho”; each of IDEXX and Ortho also a “Party” and together also the “Parties”).

Sample 1
AMENDMENT NO. 8 TO AGREEMENT
Certain • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances

THIS AMENDMENT NO.8 TO AGREEMENT (this “Amendment”) is made effective as of September 1, 2021, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 east Shelby Drive, Memphis Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD” or “Ortho”; each of IDEXX and Ortho also a “Party” and together also the “Parties”).

Sample 1
Director Restricted Stock Unit Agreement
Director Restricted Stock Unit Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.